Long-term use of foscarnet is associated with an increased incidence of acute kidney injury in hematopoietic stem cell transplant patients: A retrospective observational study [0.03%]
访氯磷啶长期使用与造血干细胞移植患者急性肾损伤发生率增加有关——一项回顾性观察研究
Ryo Inose,Katsuyuki Takahashi,Masaya Takahashi et al.
Ryo Inose et al.
Background: Foscarnet is an important drug for the treatment of cytomegalovirus infection in patients undergoing hematopoietic stem cell transplantation (HSCT). Foscarnet is often discontinued because of the development o...
Belatacept may result in profound and persistent loss of cytomegalovirus-specific cell-mediated immunity: A case report [0.03%]
贝拉塔西普可能导致巨细胞病毒特异性细胞介导免疫的显著且持续的丧失：病例报告
Hanna L Kleiboeker,Margaret R Jorgenson,Jeannina A Smith
Hanna L Kleiboeker
Histologic acute graft pyelonephritis after kidney transplantation: Incidence, clinical characteristics, risk factors, and association with graft loss [0.03%]
肾移植后急性移植物肾盂肾炎的组织学特征：发病率、临床特点、危险因素及与移植物丢失的关系
Harry R Powers,Walter C Hellinger,Cherise Cortese et al.
Harry R Powers et al.
Background: Histologic acute graft pyelonephritis (HAGPN) after kidney transplantation (KT) has been assessed less frequently than urinary tract infections (UTIs) or clinical acute graft pyelonephritis. Risk factors for H...
Donor-derived tuberculosis among solid organ transplant recipients in the United States-2008 to 2018 [0.03%]
2008—2018年美国器官移植受者中的供体传播结核病病例报告
Maricar Malinis,Ricardo M La Hoz,Gabriel Vece et al.
Maricar Malinis et al.
Mycobacterium tuberculosis can be transmitted via organ donation and result in severe outcomes. To better understand donor-derived tuberculosis (DDTB), all potential transmissions reported to the Organ Procurement and Transplantation Networ...
Novel risk factor for valganciclovir toxicity-NUDT15 genetic variant [0.03%]
新型核苷类似物代谢基因NUDT15变异与缬更昔洛韦毒性反应关系研究
Ashay Shingare,Nikhil Dhope,Madan M Bahadur
Ashay Shingare
Humoral immunity of BBIBP-CorV (Sinopharm) in kidney transplant recipients: Is it time to revise vaccination strategies [0.03%]
肾脏移植受者接种BBIBP-CorV(国药新冠疫苗)后的体液免疫反应：是时候修订疫苗接种策略了吗？
Mohsen Nafar,Saghar Chehrazi,Nooshin Dalili et al.
Mohsen Nafar et al.
Background: The mortality of coronavirus disease 2019 (COVID-19) is high in transplant patients, and effective vaccination is aimed to reduce severe disease and mortality. ...
Sofía de la Villa,María-Vega Catalina,Andrés Conthe
Sofía de la Villa
Alessandra Mularoni,Elena Graziano,Francesca Todaro
Alessandra Mularoni
Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis [0.03%]
Covid-19在造血干细胞移植受者中影响的系统评价和 Meta 分析
Moazzam Shahzad,Sibgha Gull Chaudhary,Muhammad U Zafar et al.
Moazzam Shahzad et al.
Background: Hematopoietic stem cell transplant (HSCT) recipients are at increased risk of mortality and morbidity with coronavirus disease 2019 (COVID-19) due to severe immune dysfunction. ...
Fatal allograft mucormycosis complicating severe COVID-19 infection and bacterial pyelonephritis [0.03%]
严重COVID-19感染和细菌性肾盂肾炎并发致死性移植物毛霉病
Abhilash Chandra,Namrata Rao S,Kiran Preet Malhotra
Abhilash Chandra
We herein present a case of live related kidney transplant recipient who initially developed severe coronavirus (COVID-19) disease associated with E.coli related pyelonephritis and graft dysfunction, who improved over one week only to deter...